The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation.
about
Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host diseaseTherapeutics for Graft-versus-Host Disease: From Conventional Therapies to Novel Virotherapeutic StrategiesInnate lymphoid cells in graft-versus-host diseaseThe role of pattern-recognition receptors in graft-versus-host disease and graft-versus-leukemia after allogeneic stem cell transplantationThe complex and central role of interferon-γ in graft-versus-host disease and graft-versus-tumor activityAdvances in predicting acute GVHDOral complications in hematopoietic stem cell recipients: the role of inflammationCeacam1 separates graft-versus-host-disease from graft-versus-tumor activity after experimental allogeneic bone marrow transplantationModulation of Immunoregulatory Properties of Mesenchymal Stromal Cells by Toll-Like Receptors: Potential Applications on GVHDHematopoetic stem cell transplantation in childrenInterleukin-18 regulates acute graft-versus-host disease by enhancing Fas-mediated donor T cell apoptosisLeukocyte migration and graft-versus-host disease.CARD15/NOD2 is required for Peyer's patches homeostasis in mice.Natural Killer Cells in Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation.Noninvasive tracking of donor cell homing by near-infrared fluorescence imaging shortly after bone marrow transplantationCurrent and future approaches for control of graft-versus-host disease.Lung parenchyma-derived IL-6 promotes IL-17A-dependent acute lung injury after allogeneic stem cell transplantationIntestinal damage determines the inflammatory response and early complications in patients receiving conditioning for a stem cell transplantationCan antigen-specific regulatory T cells protect against graft versus host disease and spare anti-malignancy alloresponse?TLR/MyD88-mediated Innate Immunity in Intestinal Graft-versus-Host DiseaseInsufficient evidence for association of NOD2/CARD15 or other inflammatory bowel disease-associated markers on GVHD incidence or other adverse outcomes in T-replete, unrelated donor transplantation.Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia.The biology of graft-versus-host disease: experimental systems instructing clinical practice.Treatment with a rho kinase inhibitor improves survival from graft-versus-host disease in mice after MHC-haploidentical hematopoietic cell transplantation.Palifermin for the protection and regeneration of epithelial tissues following injury: new findings in basic research and pre-clinical models.Advances in graft-versus-host disease biology and therapy.Pathogenesis and management of graft-versus-host disease.Modeling human gastrointestinal inflammatory diseases using microphysiological culture systems.Up-Regulation of alpha4beta7 integrin on peripheral T cell subsets correlates with the development of acute intestinal graft-versus-host disease following allogeneic stem cell transplantation.Recipient NK cell inactivation and intestinal barrier loss are required for MHC-matched graft-versus-host disease.Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantationComparison of reduced-intensity and myeloablative conditioning regimens for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia and acute lymphoblastic leukemia: a meta-analysis.The Wnt agonist R-spondin1 regulates systemic graft-versus-host disease by protecting intestinal stem cells.Enhanced allostimulatory activity of host antigen-presenting cells in old mice intensifies acute graft-versus-host diseaseHDAC inhibition and graft versus host diseaseBiomarkers in chronic graft-versus-host diseaseAbrogation of donor T-cell IL-21 signaling leads to tissue-specific modulation of immunity and separation of GVHD from GVLA prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre studyIFN-gamma-induced TNFR2 expression is required for TNF-dependent intestinal epithelial barrier dysfunctionPrevention of GVHD while sparing GVL effect by targeting Th1 and Th17 transcription factor T-bet and RORγt in mice.
P2860
Q24626202-8792FCE5-9673-428F-B249-1365FE9B596AQ26751959-94E2E8C7-F394-455A-A7BE-2C1721A564E5Q26801315-BB7695B6-2C6E-455B-9B0C-E4AFCE63B612Q26824436-C1AF1FC0-94F3-4DA5-A52E-116BCCCD0709Q26851545-F0D4F871-AF2F-4EEE-96C0-054E1FAA6C36Q27021123-B610AB86-716E-49F6-A6A1-E15345D20715Q27027650-DE070EB3-E363-4867-A7B3-8E7607D132E6Q27334243-03E71360-61D4-4549-B215-26F5569870C0Q28077242-2758C0FD-26E9-46E6-992F-AC81AC87DC11Q28088687-5E85B214-6188-4CC4-890A-D201C2D838C6Q28591879-3457E1DA-28D8-4BE0-9E04-296394FD85A7Q30479618-07DA9F7D-316B-440F-B7BB-378841218CEAQ33287474-A75A6290-DAA1-4D30-B554-4806140B3BCAQ33600093-EEA72626-52A9-4F12-82F5-E6002BE7148FQ33608672-A8BC16FD-92D6-457C-B38B-CD8803B54EA2Q33642625-3C720F94-738E-4338-881B-ECB5FB6806ACQ33758318-DB45FA9F-E0A5-4E09-83C1-4A6B03E59235Q33781213-16CE6B01-B694-443A-A36C-6ADEBD162C1DQ33800533-8D35E464-8E35-4D81-9165-2A5570415BCFQ33835099-56B1DDA8-C46B-44F7-AA9A-3C4C651C2C64Q33839876-0C94BEA3-05F3-4407-8A72-B3A1C3AD9646Q33868328-6D9B4023-4045-4E1E-97E2-8474E85C9525Q33917175-D5E5AEC2-CBC6-4CE3-AE3B-4131E853D9AEQ33918485-9754087D-F6E2-4149-94C0-B9366E993759Q33985578-1FB61339-372B-42BE-9691-F619B8BE4790Q34031916-3D9A3FCB-CDAD-48F7-9866-7966C6E72AD7Q34077479-0525F059-6AAE-4116-A1ED-EE52E981EFF3Q34143148-AE040D37-6016-4138-BE27-0A7AC5CF4713Q34156279-32297C24-778D-46BA-8297-9F3378FD71B4Q34167845-28258464-1E07-46E0-84EF-E682B824A0FDQ34311369-83549811-A260-4A52-B998-0218815DC5C6Q34360641-2E46EC55-7181-4219-97C9-E5071267B725Q34577694-E3C43076-1A2D-471D-94B2-79769A0087DBQ34791351-25F5C03B-9EC2-4B15-A417-EFE597B4C58BQ35016985-89CB0DC1-65F6-4387-92C4-FCE76AF69CB2Q35094374-37EF362A-FD82-4B89-A24B-7E7531C15F64Q35112265-CA99924A-A8D3-4DF2-8083-1762CA8E951DQ35120338-8FBF7EB9-693C-4506-8F2E-19935EB17765Q35215366-C3A8E351-C8A6-43A1-A797-F3A6F2B63157Q35525708-9F5D131B-8D6B-493E-A67C-84D04E3742E1
P2860
The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The primacy of the gastrointes ...... c bone marrow transplantation.
@ast
The primacy of the gastrointes ...... c bone marrow transplantation.
@en
type
label
The primacy of the gastrointes ...... c bone marrow transplantation.
@ast
The primacy of the gastrointes ...... c bone marrow transplantation.
@en
prefLabel
The primacy of the gastrointes ...... c bone marrow transplantation.
@ast
The primacy of the gastrointes ...... c bone marrow transplantation.
@en
P1433
P1476
The primacy of the gastrointes ...... c bone marrow transplantation.
@en
P2093
P304
P407
P577
2000-05-01T00:00:00Z